TAI-95 | CAS# 1438638-83-5 | Hec1 Inhibitor

MedKoo Cat#: 565057 | Name: TAI-95

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TAI-95 is an inhibitor of highly expressed cancer protein 1 (Hec1).

Chemical Structure

TAI-95

CAS#1438638-83-5 (free base)

Theoretical Analysis

MedKoo Cat#: 565057

Name: TAI-95

CAS#: 1438638-83-5 (free base)

Chemical Formula: C24H23N5O3S2

Exact Mass: 493.1242

Molecular Weight: 493.60

Elemental Analysis: C, 58.40; H, 4.70; N, 14.19; O, 9.72; S, 12.99

Price and Availability

Size	Price	Availability	Quantity

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

1438638-83-5 (free base) 2250404-95-4 (tosylate)

Synonym

TAI95; TAI 95; TAI-95

IUPAC/Chemical Name

N-[4-[4-[[5-(2-Methoxyethoxy)-2-pyrazinyl]thio]-2,6-dimethylphenyl]-2-thiazolyl]-4-pyridinecarboxamide

InChi Key

ICECVTFTHRPNOE-UHFFFAOYSA-N

InChi Code

InChI=1S/C24H23N5O3S2/c1-15-10-18(34-21-13-26-20(12-27-21)32-9-8-31-3)11-16(2)22(15)19-14-33-24(28-19)29-23(30)17-4-6-25-7-5-17/h4-7,10-14H,8-9H2,1-3H3,(H,28,29,30)

SMILES Code

O=C(C1=CC=NC=C1)NC2=NC(C3=C(C)C=C(SC4=NC=C(OCCOC)N=C4)C=C3C)=CS2

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 493.60 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Galvão KN, Federico P, De Vries A, Schuenemann GM. Economic comparison of reproductive programs for dairy herds using estrus detection, timed artificial insemination, or a combination. J Dairy Sci. 2013 Apr;96(4):2681-2693. doi: 10.3168/jds.2012-5982. Epub 2013 Feb 15. PMID: 23415521. 2: Huang LY, Chang CC, Lee YS, Chang JM, Huang JJ, Chuang SH, Kao KJ, Lau GM, Tsai PY, Liu CW, Lin HS, Lau JY. Activity of a novel Hec1-targeted anticancer compound against breast cancer cell lines in vitro and in vivo. Mol Cancer Ther. 2014 Jun;13(6):1419-30. doi: 10.1158/1535-7163.MCT-13-0700. Epub 2014 Apr 2. PMID: 24694948. 3: Huang LY, Chang CC, Lee YS, Huang JJ, Chuang SH, Chang JM, Kao KJ, Lau GM, Tsai PY, Liu CW, Lin HS, Gish RG, Lau JY. Inhibition of Hec1 as a novel approach for treatment of primary liver cancer. Cancer Chemother Pharmacol. 2014 Sep;74(3):511-20. doi: 10.1007/s00280-014-2540-7. Epub 2014 Jul 20. PMID: 25038613. 4: Chuang SH, Lee YE, Huang LYL, Chen CK, Lai CL, Lin YH, Yang JY, Yang SC, Chang LH, Chen CH, Liu CW, Lin HS, Lee YR, Huang KP, Fu KC, Jen HM, Lai JY, Jian PS, Wang YC, Hsueh WY, Tsai PY, Hong WH, Chang CC, Wu DZ, Wu J, Chen MH, Yu KM, Chern CY, Chang JM, Lau JYN, Huang JJ. Discovery of T-1101 tosylate as a first- in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy. Eur J Med Chem. 2020 Apr 1;191:112118. doi: 10.1016/j.ejmech.2020.112118. Epub 2020 Feb 7. PMID: 32113126. 5: Gong M, Dong H, Tang Y, Huang W, Lu F. Effects of aromatherapy on anxiety: A meta-analysis of randomized controlled trials. J Affect Disord. 2020 Sep 1;274:1028-1040. doi: 10.1016/j.jad.2020.05.118. Epub 2020 May 26. PMID: 32663929. 6: Buczkowski P, Puslecki M, Ligowski M, Dabrowski M, Stefaniak S, Fryska Z, Kulesza J, Juszkat R, Jemielity M, Perek B. Emergency Endovascular Interventions on Descending Thoracic Aorta: A Single-Center Experience. Emerg Med Int. 2023 Jan 3;2023:6600035. doi: 10.1155/2023/6600035. PMID: 36636029; PMCID: PMC9831698.